| 26.68 Delayed Data As of Oct 11 |  -0.02 / -0.07%Today’s Change | 21.75 Today|||52-Week Range 31.96 | +5.45% Year-to-Date |
| Previous close | 26.70 |
| Today’s open | 26.67 |
| Day’s range | 26.62 - 26.92 |
| Volume | 37,875 |
| Average volume (3 months) | 73,064 |
| Market cap | $3.4B |
| Earnings growth (last year) | +23.01% |
| Earnings growth (this year) | -70.81% |
| Earnings growth (next 5 years) | +2.51% |
| Revenue growth (last year) | +18.48% |
| P/E ratio | NM |
| Price/Sales | 35.17 |
| Price/Book | 6.03 |
| Today’s change | Today’s % change | |
|---|---|---|
| BPMCBlueprint Medicines ... | +1.73 | +2.40% |
| ARWRArrowhead Pharmaceut... | +0.55 | +1.72% |
| ALLOAllogene Therapeutic... | -1.01 | -3.91% |
| NKTRNektar Therapeutics | +0.96 | +5.95% |
| Next reporting date | October 30, 2019 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $90.2M |
| Annual profit (last year) | -$66.3M |
| Net profit margin | -73.48% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer Jean-Paul Kress |
Chief Financial Officer Jens Holstein |
Corporate headquarters Planegg, Bayern (bavaria) |
